Skip to main content
Top
Published in: Annals of Hematology 5/2017

01-05-2017 | Original Article

Reallocating time to sleep, sedentary, and active behaviours in non-Hodgkin lymphoma survivors: associations with patient-reported outcomes

Authors: Jeff K. Vallance, Matthew P. Buman, Brigid M. Lynch, Terry Boyle

Published in: Annals of Hematology | Issue 5/2017

Login to get access

Abstract

The purpose of this study was to examine potential effects of reallocating time between sleep, sedentary and active behaviours on fatigue symptoms and quality of life in a sample of non-Hodgkin lymphoma survivors. Non-Hodgkin lymphoma survivors identified from the Western Australian Cancer Registry (N = 149) (response rate = 36%; median age = 64 years) wore an Actigraph® GT3X+ accelerometer for 7 days and completed the Fatigue Scale, the Functional Assessment of Cancer Therapy-General and the Pittsburgh Sleep Quality Index. We used isotemporal substitution methods in linear regression models to examine the potential effects of reallocating time between sleep, sedentary and activity behaviours on fatigue and quality of life. Data collection was conducted in Western Australia in 2013. Significant differences were observed for fatigue symptoms when 30 min per day of bouted moderate-to-vigorous physical activity (10 min) was reallocated from 30 min per day of sleep (5.7 points, 95% CI = 1.8, 9.7), sedentary time bouts (20 min) (5.7 points, 95% CI = 1.6, 9.7), sedentary time non-bouts (5.1 points, 95% CI = 1.0, 9.3) or light intensity activity (5.5 points, 95% CI = 1.5, 9.5). Isotemporal substitution effects of reallocating sedentary time, sleep and light physical activity with bouted physical activity was significantly associated with fatigue, but not quality of life. Findings from the present study may aid in the development and delivery of health behaviour interventions that are more likely to influence the health outcome of interest.
Literature
1.
go back to reference American Cancer Society (2016) Cancer facts & figures 2016. American Cancer Society, Atlanta American Cancer Society (2016) Cancer facts & figures 2016. American Cancer Society, Atlanta
2.
go back to reference Oerlemans S et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hemat 90(9):993–1004CrossRef Oerlemans S et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hemat 90(9):993–1004CrossRef
3.
go back to reference Oerlemans S et al (2013) A high level of fatigue among long-term survivors of non-Hodgkin’s lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 98(3):479–486CrossRefPubMedPubMedCentral Oerlemans S et al (2013) A high level of fatigue among long-term survivors of non-Hodgkin’s lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 98(3):479–486CrossRefPubMedPubMedCentral
4.
go back to reference Mols F et al (2007) Quality of life among long-term non-Hodgkin lymphoma survivors. Cancer 109(8):1659–1667CrossRefPubMed Mols F et al (2007) Quality of life among long-term non-Hodgkin lymphoma survivors. Cancer 109(8):1659–1667CrossRefPubMed
5.
go back to reference Arden-Close E, Pacey A, Eiser C (2010) Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 51(4):628–640CrossRefPubMed Arden-Close E, Pacey A, Eiser C (2010) Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 51(4):628–640CrossRefPubMed
6.
go back to reference Jensen RE et al (2013) Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 119(3):672–680CrossRefPubMed Jensen RE et al (2013) Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 119(3):672–680CrossRefPubMed
7.
go back to reference Bergenthal N et al (2014) Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev 11:Cd009075 Bergenthal N et al (2014) Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev 11:Cd009075
8.
go back to reference Husson O et al (2015) High levels of physical activity are associated with lower levels of fatigue among lymphoma patients: results from the longitudinal PROFILES registry. Acta Oncol 54(5):678–684CrossRefPubMed Husson O et al (2015) High levels of physical activity are associated with lower levels of fatigue among lymphoma patients: results from the longitudinal PROFILES registry. Acta Oncol 54(5):678–684CrossRefPubMed
9.
go back to reference Spector DJ et al (2015) Are lifestyle behavioral factors associated with health-related quality of life in long-term survivors of non-Hodgkin lymphoma? Cancer 121(18):3343–3351CrossRefPubMedPubMedCentral Spector DJ et al (2015) Are lifestyle behavioral factors associated with health-related quality of life in long-term survivors of non-Hodgkin lymphoma? Cancer 121(18):3343–3351CrossRefPubMedPubMedCentral
10.
go back to reference Vallance JK et al (2005) Differences in quality of life between non-Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology 14(11):979–991CrossRefPubMed Vallance JK et al (2005) Differences in quality of life between non-Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology 14(11):979–991CrossRefPubMed
11.
12.
go back to reference Boyle T et al (2015) Volume and correlates of objectively measured physical activity and sedentary time in non-Hodgkin lymphoma survivors. Psychooncology. doi:10.1002/pon.4027 Boyle T et al (2015) Volume and correlates of objectively measured physical activity and sedentary time in non-Hodgkin lymphoma survivors. Psychooncology. doi:10.​1002/​pon.​4027
13.
go back to reference Lynch BM et al (2013) Don’t take cancer sitting down: a new survivorship research agenda. Cancer 119(11):1928–1935CrossRefPubMed Lynch BM et al (2013) Don’t take cancer sitting down: a new survivorship research agenda. Cancer 119(11):1928–1935CrossRefPubMed
14.
go back to reference Owen N (2012) Ambulatory monitoring and sedentary behaviour: a population-health perspective. Physiol Meas 33(11):1801–1810CrossRefPubMed Owen N (2012) Ambulatory monitoring and sedentary behaviour: a population-health perspective. Physiol Meas 33(11):1801–1810CrossRefPubMed
15.
go back to reference Owen N (2012) Sedentary behavior: understanding and influencing adults’ prolonged sitting time. Prev Med 55(6):535–539CrossRefPubMed Owen N (2012) Sedentary behavior: understanding and influencing adults’ prolonged sitting time. Prev Med 55(6):535–539CrossRefPubMed
16.
17.
go back to reference Buman MP et al (2014) Reallocating time to sleep, sedentary behaviors, or active behaviors: associations with cardiovascular disease risk biomarkers, NHANES 2005-2006. Am J Epidemiol 179(3):323–334CrossRefPubMed Buman MP et al (2014) Reallocating time to sleep, sedentary behaviors, or active behaviors: associations with cardiovascular disease risk biomarkers, NHANES 2005-2006. Am J Epidemiol 179(3):323–334CrossRefPubMed
18.
go back to reference van Roekel EH, et al.(2016) Modeling how substitution of sedentary behavior with standing or physical activity is associated with health-related quality of life in colorectal cancer survivors. Cancer Causes Control van Roekel EH, et al.(2016) Modeling how substitution of sedentary behavior with standing or physical activity is associated with health-related quality of life in colorectal cancer survivors. Cancer Causes Control
19.
go back to reference Matthews CE et al (2008) Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidem 167(7):875–881CrossRef Matthews CE et al (2008) Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidem 167(7):875–881CrossRef
20.
go back to reference Freedson PS, Melanson E, Sirard J (1998) Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 30(5):777–781CrossRefPubMed Freedson PS, Melanson E, Sirard J (1998) Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 30(5):777–781CrossRefPubMed
21.
go back to reference Dunstan DW et al (2012) Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diab Care 35(5):976–983CrossRef Dunstan DW et al (2012) Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diab Care 35(5):976–983CrossRef
22.
go back to reference United States Government (2008) 2008 physical activity guidelines for Americans. Department of Health and Human Services, Washington, DC United States Government (2008) 2008 physical activity guidelines for Americans. Department of Health and Human Services, Washington, DC
23.
go back to reference Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRefPubMed Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRefPubMed
24.
go back to reference Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13–19PubMed Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13–19PubMed
25.
go back to reference Cella DF et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579CrossRefPubMed Cella DF et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579CrossRefPubMed
26.
go back to reference Yost KJ et al (2013) The Functional Assessment of Cancer Therapy-General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymph 54(2):290–297CrossRef Yost KJ et al (2013) The Functional Assessment of Cancer Therapy-General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymph 54(2):290–297CrossRef
27.
go back to reference Cella D et al (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales. J Pain Sympt Manag 24(6):547–561CrossRef Cella D et al (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales. J Pain Sympt Manag 24(6):547–561CrossRef
28.
go back to reference Osoba D et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144CrossRefPubMed Osoba D et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144CrossRefPubMed
29.
go back to reference Phillips SM et al (2015) Objectively measured physical activity and sedentary behavior and quality of life indicators in survivors of breast cancer. Cancer 121(22):4044–4052CrossRefPubMedPubMedCentral Phillips SM et al (2015) Objectively measured physical activity and sedentary behavior and quality of life indicators in survivors of breast cancer. Cancer 121(22):4044–4052CrossRefPubMedPubMedCentral
30.
go back to reference Vallance JK et al (2014) Associations of objectively-assessed physical activity and sedentary time with health-related quality of life among colon cancer survivors. Cancer 120(18):2919–2926CrossRefPubMed Vallance JK et al (2014) Associations of objectively-assessed physical activity and sedentary time with health-related quality of life among colon cancer survivors. Cancer 120(18):2919–2926CrossRefPubMed
32.
go back to reference Kozey-Keadle S et al (2011) Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc 43(8):1561–1567CrossRefPubMed Kozey-Keadle S et al (2011) Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc 43(8):1561–1567CrossRefPubMed
33.
go back to reference Mekary RA et al (2013) Isotemporal substitution analysis for physical activity, television watching, and risk of depression. Am J Epidemiol 178(3):474–483CrossRefPubMedPubMedCentral Mekary RA et al (2013) Isotemporal substitution analysis for physical activity, television watching, and risk of depression. Am J Epidemiol 178(3):474–483CrossRefPubMedPubMedCentral
34.
go back to reference Stamatakis E et al (2015) All-cause mortality effects of replacing sedentary time with physical activity and sleeping using an isotemporal substitution model: a prospective study of 201,129 mid-aged and older adults. Int J Behav Nutr Phys Act 12:12CrossRef Stamatakis E et al (2015) All-cause mortality effects of replacing sedentary time with physical activity and sleeping using an isotemporal substitution model: a prospective study of 201,129 mid-aged and older adults. Int J Behav Nutr Phys Act 12:12CrossRef
Metadata
Title
Reallocating time to sleep, sedentary, and active behaviours in non-Hodgkin lymphoma survivors: associations with patient-reported outcomes
Authors
Jeff K. Vallance
Matthew P. Buman
Brigid M. Lynch
Terry Boyle
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2942-9

Other articles of this Issue 5/2017

Annals of Hematology 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine